跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTECAN WOCKHARDT irinotecan hydrochloride 40mg/2mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
IRINOTECAN WOCKHARDT irinotecan hydrochloride 40mg/2mL injection vial
Approved
STANDARD
IRINOTECAN WOCKHARDT irinotecan hydrochloride 40mg/2mL injection vial
Wockhardt Bio Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9a1d2ff5e816de72
Company
Wockhardt Bio Pty Ltd
Type
Standard
Approval Details
Approval Id
9a1d2ff5e816de72
Product Name
IRINOTECAN WOCKHARDT irinotecan hydrochloride 40mg/2mL injection vial
Artg Id
272857
Artg Name
IRINOTECAN WOCKHARDT irinotecan hydrochloride 40mg/2mL injection vial
Sponsor
Wockhardt Bio Pty Ltd
Company Detail Path
/organization/wockhardt-bio-pty-ltd
Artg Date
2017-10-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e0c951b60466e5f7e862f719b5d157c8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9a1d2ff5e816de72
Type
Standard
Back to TGA Approvals
